MENUNews and Events
Recent Releases
03/31/2025 - 10:30am
Rogel Cancer Center at AACR 2025
Rogel Cancer Center and University of Michigan researchers will be represented in more than 60 presentations and poster sessions. Check the list below to support your colleagues. All times listed are Central Time.
03/25/2025 - 3:45pm
An emerging class of RNA fighting cancer, infectious and genetic diseases
Cancer antigen-encoding RNA vaccines, or circRNA, is a targeted technology that improves existing immunotherapy and vaccine approaches
03/25/2025 - 3:30pm
Histotripsy can help release HER2 from cancer tumor cells
A revolutionary new therapy, called histotripsy uses soundwaves to destroy liver tumors and was approved for clinical use by the FDA in 2023. A recent study in the journal Cancers demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.
03/25/2025 - 3:15pm
Re-purposed FDA-approved drug could help treat high-grade glioma
Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma
03/25/2025 - 12:45pm
New cellular therapy trials for brain tumors
The standard treatment for most cancers is chemotherapy and surgery. However, for tumors in the brain and spinal cord treatments can be challenging, because they are often difficult to access due to their location and can be very aggressive. Unfortunately, there are limited therapy options for patients with inoperable tumors. The development of chimeric antigen receptor T cells is a promising new type of cancer therapy. CAR T treatment helps the patient’s own body and immune system to target the tumor.
Publications
